Results 71 to 80 of about 6,114 (196)

The atypical antidepressant mianserin exhibits agonist activity at κ‐opioid receptors

British Journal of Pharmacology, 2012
M. Olianas, S. Dedoni, P. Onali
semanticscholar   +1 more source

Computational approach to the prediction of blood-brain partitioning of basic drug candidates using mixed micellar liquid chromatography

مجله دانشگاه علوم پزشکی گرگان, 2017
Background and Objective: The blood–brain barrier (BBB) is considered to be the main barrier to drug transport into the central nervous system. In this study, the capability of biopartitioning micellar chromatography (BMC) using the mixed micellar system
S Arshadi
doaj  

Analgesic Efficacy and Tolerability of Amitriptyline versus Mianserin in Chronic Low Back Pain: A Randomised, Double-Blind, Controlled Pilot Trial. [PDF]

J Pain Res
Wangnamthip S, Eiamtanasate S, Saisavoey N, Sathienluckana T, Suthisiltham L, Panchoowong S, Tipapakoon I, Euasobhon P, Jensen MP, Srirojanakul W.   +9 more
europepmc   +1 more source

Antidepressant metabolite concentrations and metabolite-to-parent drug ratios in postmortem femoral blood. [PDF]

J Anal Toxicol
Kriikku P, Ojanperä I.
europepmc   +1 more source

Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy

Journal of Neurology Neurosurgery & Psychiatry, 1999
H. Palomäki, Markku Kaste, Anu Berg, Riitta Lönnqvist, Jouko Lönnqvist, M. Lehtihalmes, Juhani Hares   +6 more
semanticscholar   +1 more source

Interferon-primed immune landscapes predict immune-related adverse events during immune checkpoint inhibitor therapy. [PDF]

Front Cell Dev Biol
Kang J, Huang R, Chen Y, Yu Y, Li X, Yong X, Ao G, Yang Q.   +7 more
europepmc   +1 more source

Unlocking neuronal health: leveraging C. elegans for drug repurposing studies. [PDF]

Cell Commun Signal
Gowda S, Kumar A, Topf U.
europepmc   +1 more source

Enhanced inhibitory effects of mianserin in combination with sorafenib on liver cancer growth through targeting the CCR9-AKT pathway. [PDF]

Am J Cancer Res
Huang YH, Liao CJ, Wu MH, Lai MW, Yeh YH, Yeh CT, Lin YH, Lin KH.   +7 more
europepmc   +1 more source

Noradrenergic system involvement as a major driver of tension-type headache: a systematic review of the current evidence. [PDF]

J Headache Pain
Braca S, Cretella G, Deligianni C, Kennelly L, Tseriotis VS, Andreou AP, Mitsikostas DD, Mavridis T.   +7 more
europepmc   +1 more source

Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis. [PDF]

Br J Psychiatry
De Luca B, Canozzi A, Mosconi C, Gastaldon C, Papola D, Metelli A, Tedeschi F, Amaddeo F, Purgato M, Solmi M, Barbui C, Vita G, Ostuzzi G.   +12 more
europepmc   +1 more source